Life Sciences BC Selects 2027 Investor Readiness Program Cohort to Support Growth of Emerging Life Sciences Companies Life Sciences BC (LSBC) has announced the companies selected to participate in its 2027 Investor Readiness Program (IRP), a six-month initiative designed to…
Invivoscribe Launches Complete LymphoTrack Flex Suite for NGS-Based Clonality and MRD Analysis Invivoscribe, a global provider of precision diagnostics and measurable residual disease (MRD) testing solutions, has announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing…
BioCentury Opens Registration for 2027 Grand Rounds Conference in Houston BioCentury has announced that registration is now open for the sixth edition of BioCentury Grand Rounds: US, a translational science-focused conference scheduled for April 12–14, 2027, in Houston, Texas. The…
Travere to Present New FILSPARI Data in IgA Nephropathy and FSGS at ASN Kidney Week 2026 Travere Therapeutics, Inc. (Nasdaq: TVTX) is set to present nine new data analyses, including five oral presentations, at the American Society of Nephrology (ASN)…
Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial-Scale Facility for Lead-212 Targeted Alpha Therapies Orano Med, a subsidiary of the Orano Group and a pioneer in targeted alpha therapies for cancer, has inaugurated ATLab Valenciennes, an industrial-scale pharmaceutical manufacturing facility…
LISTERINE® Launches Oral Care Counts Initiative to Highlight the Essential Role of Oral Health in Overall Wellbeing LISTERINE® is launching Oral Care Counts, a multiyear education and advocacy initiative designed to raise awareness of the importance of oral health as…
Blue Matter Launches Behavioral Science Center of Excellence to Strengthen Biopharma Market Research and Decision-Making Blue Matter has announced the launch of its Behavioral Science Center of Excellence (BeSci CoE), a specialized capability within the company’s Blue Matter Insights primary…
Fresenius Kabi Receives 2026 Vizient Pharmacy Strategic Programs Excellence Award Fresenius Kabi, part of global healthcare company Fresenius, has received the 2026 Pharmacy Strategic Programs Excellence Award from Vizient, a provider-driven healthcare performance improvement company in the United States. The…
CytoAgents Presents Preclinical Data Supporting CTO1681 in Atopic Dermatitis at EADV Congress 2026 CytoAgents, Inc., a clinical-stage biotechnology company developing CTO1681, an oral, steroid-sparing immunomodulator for diseases associated with dysregulated inflammation, has announced the presentation of new preclinical findings evaluating…
Alnylam Launches ‘Play by Play’ Initiative to Raise Awareness of ATTR-CM and Support Earlier Diagnosis Alnylam Pharmaceuticals, Inc., a company focused on RNA interference (RNAi) therapeutics, has launched “AMVUTTRA® ‘Play by Play,’” a new U.S. educational initiative designed to raise…
Asahi Kasei Unifies Global Pharmaceutical Operations Under Asahi Kasei Therapeutics Brand Asahi Kasei has announced plans to bring its pharmaceutical businesses in Japan, the United States, Sweden and Germany together under the Asahi Kasei Therapeutics brand, establishing a unified global…
Breast Cancer Canada Survey Highlights Demand for More Consistent and Coordinated Breast Cancer Care Breast Cancer Canada, a national charity focused on advancing breast cancer research and improving outcomes for patients, has released new national survey findings showing strong public…